Trials / Completed
CompletedNCT01553734
Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 148 (actual)
- Sponsor
- HaEmek Medical Center, Israel · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The macrolide group of antibiotics can cause QT prolongation, and endanger the patient with life threatening arrythmias. QT prolongation caused by Azythromycin, a relatively new macrolide, is extremely rare, and was not reported in clinical trials. Our hypothesis is that patients hospitalized with severe community acquired pneumonia, usually with multiple comorbid conditions will have a higher rate of QT prolongation, compared to the clinical trials published
Detailed description
Patients hospitalized with community aquired pneumonia will have their corrected QT measured daily during antibiotic therapy. Concomittant medications and electrolyte abnormalities that cause prolonged QT will be recorded
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2012-03-14
- Last updated
- 2016-08-31
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01553734. Inclusion in this directory is not an endorsement.